Literature DB >> 22109721

Frequency distribution of the single-nucleotide -108C/T polymorphism at the promoter region of the PON1 gene in Asian Indians and its relationship with coronary artery disease.

Imteyaz Ahmad1, Rajiv Narang, Anand Venkatraman, Nibhriti Das.   

Abstract

A single-nucleotide promoter region polymorphism (-108C/T) of the paraoxonase (PON1) gene had been suggested to influence an individual's susceptibility to coronary artery disease (CAD). No data is available on this polymorphism from India. One hundred seventy-eight healthy individuals and 204 angiographically proven CAD patients were recruited to get baseline data on the frequency distribution of the -108C/T polymorphism in normal people of Asian Indian ethnicity and its relation with the risk of CAD. Polymerase chain reaction followed by restriction fragment length analysis was used as the method for genotyping. Blood samples were used for DNA isolation. In the normal subjects, the genotypes were distributed as CT (43.26%) > CC (30.34%), >TT (26.4%). The allele frequency of the C allele was 0.52, and that of the T allele was 0.48. The patients showed a similar pattern, but the TT genotype was about two times more frequent in the controls than in patients. Odds ratios for developing CAD for individuals with CT, TT, and CT + TT genotypes were 0.89 (0.50-1.59), 0.56 (0.27-1.08), and 0.76 (0.44-1.29), respectively (at 95% confidence interval), when compared to CC homozygous people (age- and sex-adjusted, p = 0.114, all genotypes compared). This suggested a trend for the T allele as protective against CAD. This first report on the frequency distribution of the -108C/T polymorphism in people of Asian Indian ethnicity suggests that the normal distribution is similar to that observed for the Chinese, Japanese, and Latino people, but the disease association is unique. The TT genotype and the T allele which are widely found associated with the risk of CAD showed a protective trend in this study.

Entities:  

Year:  2011        PMID: 22109721      PMCID: PMC3186014          DOI: 10.1007/s12687-011-0037-1

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  37 in total

1.  Variability of the paraoxonase gene (PON1) in Euro- and Afro-Brazilians.

Authors:  Karla V Allebrandt; Ricardo L R Souza; Eleidi A Chautard-Freire-Maia
Journal:  Toxicol Appl Pharmacol       Date:  2002-05-01       Impact factor: 4.219

2.  Serum esterases. I. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination.

Authors:  W N ALDRIDGE
Journal:  Biochem J       Date:  1953-01       Impact factor: 3.857

3.  Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies.

Authors:  Jeremy G Wheeler; Bernard D Keavney; Hugh Watkins; Rory Collins; John Danesh
Journal:  Lancet       Date:  2004-02-28       Impact factor: 79.321

Review 4.  Paraoxonase and atherosclerosis.

Authors:  P N Durrington; B Mackness; M I Mackness
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

5.  A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression.

Authors:  T Suehiro; T Nakamura; M Inoue; T Shiinoki; Y Ikeda; Y Kumon; M Shindo; H Tanaka; K Hashimoto
Journal:  Atherosclerosis       Date:  2000-06       Impact factor: 5.162

6.  Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII.

Authors:  B Garner; A R Waldeck; P K Witting; K A Rye; R Stocker
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

7.  Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.

Authors:  V H Brophy; R L Jampsa; J B Clendenning; L A McKinstry; G P Jarvik; C E Furlong
Journal:  Am J Hum Genet       Date:  2001-05-02       Impact factor: 11.025

8.  Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis.

Authors:  D M Shih; L Gu; Y R Xia; M Navab; W F Li; S Hama; L W Castellani; C E Furlong; L G Costa; A M Fogelman; A J Lusis
Journal:  Nature       Date:  1998-07-16       Impact factor: 49.962

9.  Serum esterases. II. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera.

Authors:  W N ALDRIDGE
Journal:  Biochem J       Date:  1953-01       Impact factor: 3.857

10.  Paraoxonase polymorphisms, haplotypes, and enzyme activity in Latino mothers and newborns.

Authors:  Nina Holland; Clement Furlong; Maria Bastaki; Rebecca Richter; Asa Bradman; Karen Huen; Kenneth Beckman; Brenda Eskenazi
Journal:  Environ Health Perspect       Date:  2006-07       Impact factor: 9.031

View more
  2 in total

1.  Association between PON1 rs662 polymorphism and coronary artery disease.

Authors:  T Liu; X Zhang; J Zhang; Z Liang; W Cai; M Huang; C Yan; Z Zhu; Y Han
Journal:  Eur J Clin Nutr       Date:  2014-06-11       Impact factor: 4.016

2.  Single nucleotide polymorphisms associated with non-contact soft tissue injuries in elite professional soccer players: influence on degree of injury and recovery time.

Authors:  Ricard Pruna; Rosa Artells; Jordi Ribas; Bruno Montoro; Francesc Cos; Carme Muñoz; Gil Rodas; Nicola Maffulli
Journal:  BMC Musculoskelet Disord       Date:  2013-07-26       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.